RISK FACTORS AND EARLY DETECTION STRATEGIES IN BREAST NEOPLASMS: A 5-YEAR SYSTEMATIC REVIEW
Article Sidebar
Main Article Content
Abstract
Breast neoplasms remain a major global health concern and represent one of the leading causes of cancer-related morbidity and mortality among women. Understanding both modifiable and non-modifiable risk factors, together with implementing effective early detection strategies, is essential for improving prognosis and reducing disease burden.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1.Gao, Y., Moy, L., & Heller, S. L. (2021). Digital breast tomosynthesis: Update on technology, evidence, and clinical practice. Radiologic Clinics of North America, 59(1), 1–15.
2.Hernández, M. L., Oseni, T. O., & Pisano, E. D. (2020). Abbreviated MRI for breast cancer screening: Current evidence and future directions. Academic Radiology, 27(2), 179–187.
3.Lukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021). Breast cancer—Epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Cancers, 13(17), 4287.
4.Luker, G. D., et al. (2020). MRI screening reduces interval breast cancer in women with dense breasts. Journal of Clinical Oncology, 38(15), 1675–1685.
5.Petrucelli, N., Daly, M. B., & Feldman, G. L. (2023). BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In GeneReviews®. University of Washington, Seattle.
6.Ren, W., et al. (2022). Global guidelines for breast cancer screening: A systematic review. Journal of Global Oncology, 8, e2100423.
7.Zheng, Y., et al. (2022). Risk-adapted breast cancer screening strategies based on individual risk profiles: Current evidence and future perspectives. Frontiers in Oncology, 12, 965060.